By regulating the mitochondrial Ca2+ overload via the MCU inhibitor KB-R7943, mitophagy and xenophagy were rectified both in vitro and in vivo, thus promoting bacterial clearance and inflammatory reduction in the CF airways [156]. This evidence concerns the gene MCU and cystic fibrosis.